Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Background male breast cancer is uncommon and studies regarding the potential clinical
relevance of the histopathological and immunohistochemical features are infrequently …

Male breast carcinoma (MBC) accounts for only 1% of total mammary carcinomas.
Controversy exists about whether MBC differs clinically and pathologically from female …

BACKGROUND Although breast cancer in men is far less common than breast cancer in
women, it is associated with a less favorable prognosis. Conventional histopathologic …

BACKGROUND In contrast to female breast carcinoma, information regarding the
prevalence and prognostic information of new molecular markers is limited in male breast …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Introduction Male breast cancer accounts for around 1% of all breast cancer cases but the
incidence has risen in recent years. This study aimed to classify the molecular subtypes of …

The proliferative activity of male breast carcinoma has been investigated using the staining
of the argyrophilic nucleolar organizer regions (AgNORs), the monoclonal antibody against …

Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …

Breast cancer in men is a rare condition affecting only 1,000 men each year in the United
States. Hormonal, genetic, and perhaps environmental factors appear to be important in …